Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004215-21Phase 3Completed
Phase 3, randomised, double-blind trial of adapalene + benzoyl peroxide, adapalene and benzoyl peroxide in acne vulgaris (4 arms), sponsored by Galderma. Primary endpoint: Success rate at Week 12. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004215-21.